AT
Applied Therapeutics Inc
🇺🇸XNAS.APLTUnited StatesHealthcare
$0.11USDup +0.01 (+10%)OpenDelayed5:49 PM
Price$0.11+0.01 (+10%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US03828A1016
- CUSIP
- 03828A101
Company
- Employees
- 28
- Headquarters
- New York, United States
- CEO
- Mr. Les D. Funtleyder
Market
- Shares outstanding
- 144.3M
- Market cap
- $15.87M
Highlights
- Market cap
- $15.87M
- EPS LTM
- -$0.13calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.88calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $999K+573.46%up year on year
- Net income
- -$18.14M+90.32%up year on year
- Gross margin
- -1,677.78%-112.66%down year on year
- Free cash flow
- -$86.85M-6.12%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.